Arachidonic Acid Treatment Against Schistosomiasis Infection in Children
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
Randomized Controlled Trial:
The investigational materials used in this trial were administered to subjects each day by
trained clinicians.
Primary Objectives:
- assess the effect of dietary supplementation with arachidonic acid on the cure rates for
Schistosomiasis mansoni with and without concomitant treatment with praziquantel.
- assess the safety of dietary supplementation using arachidonic acid in children with
clinically confirmed schistosomiasis mansoni infection.
Secondary objective:
- to measure changes in total phospholipids in plasma.
Phase:
N/A
Details
Lead Sponsor:
DSM Nutritional Products, Inc.
Collaborators:
Cairo University High Institute of Public Health, Egypt National Liver Institute, Egypt